JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...
JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...